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ABSTRACT 
 
Malaysia is one of the world’s 12 mega biodiversity, countries with the 
oldest rainforest. The most highly demanded non-timber forest products (NTFPs) 
are medicinal plants. The present case study was conducted in Pondok Tanjung 
Forest Reserve (PTFR), Perak on two ha plots using 100 subplots sized of 10m x 
10m systematic strip line sampling and questionnaire-based methods. All trees 
with medicinal value were enumerated, measured and identified based on its major 
uses in traditional medicine practices. Results showed that there were 1862 
individual plants with 102 species in 67 genera and 47 families. The most 
abundant species was Thottea grandiflora Rottb. (19.12%) and the largest family 
was  Aristolochiaceae (19.12%). The traded medicinal plants were categorized into 
four groups of habits that are climbers (40%), trees (39%), shrubs (19%) and herbs 
(2%). Results show that 1862 traded medicinal plants were classified into 
economically first rating (365 individuals or 19.60%), second rating 
(1041individuals or 55.91%), third rating (384 individuals or 20.62%) and fourth 
rating (72 individuals or 3.87%). The first, second, third and fourth economic rating 
based on demand gave the estimated average potential value of RM 2292.73 ha-¹, 
RM 3571.74 ha-¹, RM 1760.38 ha-¹ and RM 268.90 ha-¹, respectively. The largest 
family of first rating medicinal plants was Melastomataceae followed by 
Annonaceae. There was significant difference in community structure between 
Compartment 31 (Plot 1) and Compartment 11 (Plot 2), MRPP test, p ≤ 0.05 with 
soil texture sandy and sandy-clay, respectively.  The average estimated potential 
values of the traded medicinal plants calculated in both compartments per hectare-
basis was RM 7893.75 ha-¹. Two species Labisia pumila (Blume) Fern.-Vill (Kacip 
 xviii
 xix
Fatimah) and Thottea grandiflora Rottb. (Gerham Badak) have the highest average 
potential value of RM 659.81 ha-¹ (175 individual plants or 8.36.7%) and RM 
447.41 ha-¹ (356 individual plants or 5.67%), respectively.  The average net 
revenue for active Traditional Medicinal Practitioners (TMPs) was RM 4501.56 yr-¹ 
while the less active TMPs showed average net revenue of RM 1358.2 yr-¹. These 
two groups were classified based on their years of experience, expertise and broad 
knowledge especially in identifying the medicinal plants with their local names, 
utilization, market price and green price at local demand. The involvement, 
knowledge and reliability of the information obtained from the active TMPs helped 
very much in producing good estimated potential values of the traded medicinal 
plants in the study area as well as the net revenue of the TMPs.  
 
KOMPOSISI SPESIES, PENGGUNAAN DAN NILAI EKONOMI 
TUMBUHAN UBATAN: SATU KAJIAN KES DI HUTAN SIMPAN 
PONDOK TANJUNG, PERAK 
 
Malaysia adalah tergolong di dalam 12 mega kepelbagaian biologi, negara  
hutan hujan tropika yang tertua. Kajian ini dilaksanakan di Hutan Simpan 
Pondok Tanjung  (HSPT), Perak di atas plot 2 ha yang terbahagi kepada 100 
subplot dengan ukuran 10mx10m menurut sistem jalur garisan persampelan 
dan metodologi berasaskan soalselidik. Semua tumbuhan yang bernilai ubat-
ubatan dikira, diukur dan dikenalpasti berdasarkan kegunaan umum di dalam 
amalan perubatan tradisional. Hasil penyelidikan menunjukkan bahawa 
terdapat 1862 individu tumbuh-tumbuhan ubatan yang terdiri daripada 102 
spesies dalam 67 genera dan  47 famili. Spesies terbanyak adalah  Thottea 
grandiflora Rottb. (19.12%) dan famili terbesar adalah Aristolochiaceae 
(19.12%). Tumbuh-tumbuhan ubatan ini dikategorikan kepada 4 kumpulan 
berdasarkan sifat pokok dengan peratus tertinggi iaitu pokok pepanjat (40%), 
pokok (39%), renik (19%) dan herba (2%). Hasil menunjukkan bahawa  1862 
individu tumbuhan boleh dikelasifikasikan secara ekonomi kepada 
pemeringkatan satu (365 tumbuhan atau 19.60%), pemeringkatan  dua (1041 
tumbuhan atau 55.91%), pemeringkatan tiga (384 tumbuhan atau 20.62%) dan 
pemeringkatan empat (72 tumbuhan atau 3.87%). Anggaran purata nilai 
potensi untuk pemeringkatan satu adalah RM 2292.73 ha-¹, kedua RM 3571.74 
ha-¹, ketiga RM 1760.38 ha-¹, dan keempat RM 268.90 ha-¹. Famili terbesar 
dalam pemeringkatan satu tumbuh-tumbuhan ubatan adalah Melastomataceae 
diikuti dengan Annonaceae. Terdapat perbezaan yang signifiken di dalam 
 xx
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struktur komuniti tumbuhan di antara  kedua kompartmen 31 (Plot1) dan 
Kompartmen 11 (Plot 2) melalui ujian Multi Response Permutation Procedure 
(MRPP), p ≤ 0.05 dengan tekstur tanah berpasir dan berpasir-tanah liat.  
Anggaran purata nilai potensi tumbuh-tumbuhan ubatan yang diperolehi di 
dalam Kompartmen 31 dan Kompartmen 11 (Plot 2) hutan tersebut 
berdasarkan per ha adalah RM 7893.75 ha-¹. Spesies tumbuhan dari famili 
Myrsinaceae  iaitu Labisia pumila (Blume) Fern.-Vill (Kacip Fatimah) 
mempunyai purata nilai potensi tertinggi sebanyak  RM 659.81 ha-¹ (175 pokok, 
8.36%). Purata pendapatan sebenar untuk Pengamal Perubatan Tradisional 
(PPT) yang aktif adalah sebanyak RM 4501.56 thn-¹, sedangkan PPT yang 
kurang aktif menunjukkan purata pendapatan sebenar sebanyak RM 1358.20 
thn-¹. Dua kumpulan ini dikelasifikasikan berdasarkan tempoh pengalaman, 
kepakaran dan ilmu pengetahuan yang luas terutama di dalam mengenalpasti 
tumbuh-tumbuhan ubatan dengan nama tempatan, kegunaan, harga pasaran 
segar pada permintaan tempatan. Kesahihan maklumat yang diperolehi 
daripada PPT aktif banyak membantu di dalam menentukan anggaran nilai 
potensi tumbuh-tumbuhan ubatan yang diperolehi untuk diproses dan 
diniagakan  dari dalam kawasan kajian dan juga termasuk pendapatan bersih 
PPT.  
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CHAPTER 1 
 
1.0 INTRODUCTION 
 
1.1 General Introduction 
 
The forest ecosystem is an important source of non-timber forest products 
(NTFPs) and usually forms the dominant natural ecosystem in tropical 
countries. The forest provides a main source of food to local people, a wide 
variety of materials used in medicine, a source of eco-tourism and recreation 
opportunities, and helps maintain favorable environmental conditions. According 
to Panayotou and Ashton (1992), NTFPs provide some subsistence needs for 
people living near a forest (rural people) and could generate employment, 
income and materials for industry. 
 
According to the National Forestry Act (NFA), 1984, all the forest resources 
located in the forest reserve or in the state land are under the management of 
the state authority and nobody is allowed to collect or gain from any of the 
resources without permission from the state authority. In the past, the main 
emphasis of forest management in Malaysia has been for timber production and 
less attention was given to NTFPs. However, a recent approach under 
sustainable forest management has taken greater consideration of NTFPs. 
Ismail and Chin (1993) stressed that there is a need to draw up strategies to 
manage, develop and protect the NTFPs. These strategies should entail 
conservation of their genetic resources and natural heritage with the view that 
many NTFPs potentially have economic values both now and in the future.  
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Malaysian forests provide important sources of livelihood for the local 
communities living within or in the vicinity of the forests. The forest resources 
meet not only their household subsistence needs but also serve as an important 
source of income. Some of these forest products are traded while others are 
not. Valuation of forest goods used by the local community is essential in 
providing in-depth understanding on their importance to local socio-economic 
status. In 1993, the International Union for the Conservation of Nature (IUCN) 
estimated that 80% of the world’s population is using plant materials for health 
purposes. In other words, despite the advances of modern medicine, the 
practice of traditional medicine persists. Basically, some medicinal plants are 
known for their medicinal value in their roots, leaves or other parts. Their 
effectiveness and popularity depend not only on new research findings but also 
the usage experience, ethnic beliefs and the availability of the plant materials. It 
is estimated that Malaysians spend about RM1 billion in the consumption of 
traditional medicines compared to only RM600 million on pharmaceutical 
medicines (Bishop, 1998). China and India are two countries where there are 
long traditions of medicinal plant users (Lambert et al., 1996). Over the last 
decade, the World Health Assembly has passed a number of resolutions in 
response to the resurgence of interest in the study and use of traditional 
medicine in health care, and in recognition of the importance of medicinal plants 
to the health system in many developing countries. 
 
The Traditional Medicine Program of WHO is based on the reality that: 
i) The majority of the world’s population depends on traditional medicine for 
primary health care. 
 
   
                                                        3 
ii) The manpower represented by practitioners of traditional medicine is a 
potentially important resource for the delivery of health care.  
iii) Medicinal plants are of great importance to the health of individuals and 
communities. 
 
Martin (1995) defines ethnobotany as all studies concerning plants which 
describe local people’s interaction with the natural environment. The 
monumental works of Henderson (1959) in South East Asia and Burkill (1935) 
in the Malay Peninsula and other contemporary accounts in the region are all 
testimonies to thorough knowledge in local plant taxonomy and conservation. 
The current resurgence of ethnobotany occurred because the local communities 
realized the importance of botany and plant taxonomy in their economies and 
on the parts of respective authorities, serious efforts must be taken to involve 
the local communities in ethnobotanical activities, biodiversity prospecting and 
other economic activities. The Forestry Department as the custodian of the 
forest resources in the country needs to be better informed on the role of 
medicinal plants. Speculative information on the growing importance of 
traditional medicine is not sufficient for the Forestry Department to act upon. 
There is a need for clear, consistent and empirical information on the growing 
importance of medicinal plant use and the associated industry. This, if it should 
be significant, would then form the basis for the formulation of strategic action 
plan for the consolidation of medicinal plants into the current forest 
management system. 
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1.2 Economic Significance of Medicinal Plants 
 
In March 1988 an International Consultation on the Conservation of Medicinal 
Plants was convened in Chiang Mai, Thailand by WHO, in association with 
IUCN (International Union for the Conservation of Nature and Natural 
Resources) and WWF (World Wide Fund for Nature). There were two important 
outcomes of this Consultation: the first was the Chiang Mai Declaration entitled 
‘Saving Lives by Saving Plants’, and second was the generation of a set of 
guidelines which describe the various tasks that should be carried out to ensure 
that medicinal plants are conserved effectively for the future and that where 
medicinal plants are taken from the wild, they are taken on a basis that is 
sustainable (IUCN et al., 1993). Even in China and India which have fairly well 
established industries, inadequate attention is currently paid to conservation 
and cultivation programmes that would protect and enhance genetic diversity of 
medicinal plants (Lambert et al., 1996). The main features of the Chiang Mai 
Declaration (IUCN et al., 1993) were the guide lines for the conservation and 
sustainable use of medicinal plants were listed below: 
1. To ensure that any collecting from the wild is sustainable. 
2. To improve techniques for harvesting, storage and production. 
3. To study traditional knowledge on the use of plants in health care. 
4. To conserve populations of medicinal plant species in natural habitats. 
5. To conserve populations of medicinal plant species in commercial farms. 
6. Wherever possible, to cultivate the medicinal plants as the source of supply. 
7. To identify the medicinal plants, outline their distributions and assess their 
abundance. 
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8. To build public support for the conservation of medicinal plants through 
communication and cooperation. 
 
It was equally emphasized in the guidelines that no single sector, private or 
public can undertake the conservation of medicinal plants alone. The job 
requires a team effort, involving a wide range of disciplines (including 
taxonomists, ethnobotanists, traditional healers and practitioners, and park 
managers) and institutions (medical centers, village cooperatives, medical 
authorities, universities and research institutions). For any successful 
conservation and utilization of medicinal plants, a holistic approach involving all 
these groups, together with the cooperation and support of the people at the 
ground level and public needs to be harnessed (Kumari et al., 1997). 
 
Plant species are used for medicines in two ways. First, major commercial use, 
whether by prescription or over the counter sales, and secondly, as traditional 
medicines which may or may not attract a market price (Pearce & Moran, 1994). 
In the latter case two medicinal plant markets often co-exist as (a) formal – 
regulated to a limited degree by government, market crude and processed 
products with varying degrees of quality control; and (b) informal-unregulated 
without any apparent government control, provides basic healthcare,  especially 
to rural populations. 
 
The informal market is largely dependent on raw plant material. Although, the 
conservation, cultivation, collecting and processing of medicinal plant raw 
material constitute a large informal market, the exact size has never been 
objectively defined nor subjected to serious economic valuation (Lambert et al., 
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1996). Clearly, both the commercial and less formal uses have an economic 
value but what little work there has been on valuation of medicinal plants tends 
to focus on the commercial and formal markets. Few studies of trade in 
medicinal plants have been carried out often because the networks for trade in 
medicinal plants are informal and characterizing such trade is often difficult. 
Recent attempts to value medicinal plants (Balich & Mendelsohn, 1992) have 
examined only the current local market value of these products and have not 
attempted any in-depth evaluation of the benefits to rural communities of 
traditional health strategies (Brown, 1992). In addition no studies have 
attempted to place a value on the health care provided by traditional healers 
and traditional plant medicines in terms of the costs of the modern equivalents. 
The paucity of studies available however, should not obscure the likelihood that 
local willingness to pay (WTP) for traditional medicines may be substantial. 
 
The compelling argument for the identification and preservation of the world’s 
most species rich ecosystems often comes from the potential pay-off from a 
‘block-buster’ drug discovery. However, in reality the probability of a ‘discovery’ 
is often low, and the subsequent appropriation by the nation equally low or 
undefined (Pearce & Puroshotaman, 1992; Kumari, 1995). The role of plants in 
traditional medicine on the other hand provides more certain markets, and if 
systematically exploited could themselves be ‘blockbuster’ trades at the national 
level. 
 
Although many scientists still regard folk remedies somewhat skeptically, one 
should not ignore the fact that many important modern drugs (example digitoxin, 
reserpine and ephedrine) were discovered by following leads from folk 
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medicine. It is reported that 74 per cent of the 121 biologically active plant-
derived compounds presently in use worldwide, were discovered by 
researchers aimed at verifying the authenticity of information derived from folk 
ethnomedical uses of the plants (Farnsworth & Soejarto, 1985). The number of 
Malaysian rainforest plants that have been thoroughly evaluated for 
pharmacological potential remains small and the vast majority of them still have 
no identified market.  
 
Preliminary evidence for the demand of medicinal plants in Selangor and Kuala 
Lumpur comes from consumer surveys undertaken by Institute of Medical 
Research (IMR). These surveys were aggregated for the different types of 
medicinal plants used by the main ethnic groups that are the Malay, Chinese 
and Indian (Haliza, 1989). Some estimates of revenue generated through the 
sale of Chinese herbal products are also forthcoming. For example, in Malaysia, 
based only on data obtained from 4,000 Chinese herbal stores, the annual 
sales of herbal products are estimated at RM 500 million in 1994. This value 
would be higher if sales from the Malay practitioners and Indian herbal stores 
are included (Ng & Azizol, 1995).  As demand for these more popular species 
increases, their continuous harvest from the forests is likely to lead to their 
extinction. For example, two species Rafflesia hasseltii (Bunga Pakma), 
commonly used after childbirth by the Orang Asli and Eurycoma longifolia 
(Tongkat Ali), largely consumed for its aphrodisiac qualities have been heavily 
depleted in the natural forests. Although the harvest of these species is 
‘officially’ banned, the regulation is difficult to enforce in practice. 
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Preliminary trade statistics on the import and export of medicinal plants, both of 
the finished products and the raw materials shed further light on the changing 
trends in the country. The statistics show the total import value of medicinal 
plant products to have increased from RM 54 million in 1990 to RM 64 million in 
1992 (Kumari et al., 1998). There has been a corresponding decline in exports 
from RM 3.3 million to RM 1.4 million over the same two years period. The 
import of these medicinal plants comes largely from China while export on the 
other hand is largely to Singapore. The reason for this trend has been attributed 
to the increase in domestic demand for these medicinal plants. Import of raw 
plant materials for traditional medicine to Malaysia in the form of powder, pellets 
and plants is largely from Indonesia, China, Thailand, Taiwan and the US and is 
largely channeled through Singapore, Philippines, Australia and Hong Kong. 
The import of this raw material increased slightly from RM 9.6 to RM 9.8 million, 
whilst there was a corresponding decline in the export from RM 1.0 million to 
RM 0.80 million between the same two years. The suggestion again is that the 
increased domestic demand had resulted in the decline in exports, and increase 
in imports. These statistics are too preliminary to draw any major conclusions 
but the figures do suggest that there is substantial trade in medicinal products. 
These trends have to be confirmed with data over a longer time series, and 
supported with interviews with the relevant people. 
 
The date for the formal standards came into effect in January 1998. It is hoped 
that given a reasonable time frame, technical guidance and support, a 
flourishing modern pharmaceutical industry of traditional medicine will emerge 
in Malaysia which can be promoted regionally and worldwide. In response to 
these legal and administrative overtures, the Perak Forestry Department has 
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set aside 40 ha in Reserved Forest Area in Kledang Saiong, Bt Tapah, Bubu, 
Bukit Larut and Pondok Tanjung for biodiversity projects. Nona Roguy from the 
private sector has also established 1,170 ha of herbal plantation in Gua Musang 
to provide for the establishment of ‘stock’ for herbal plants as well as a ‘Good 
Manufacturing Practices’ (GMP) factory which  would allow for drug production 
to comply with the official and legal requirements (Kumari et al., 1998). 
 
The economic activities are increasing in the field of medicinal plants in 
Malaysia. The general complaint appears to be that the various groups 
(botanists, ethnobotanists, chemists, pharmacists) and agencies (public and 
private) tend to work in isolation, and that much could be gained if the issues 
and problems facing the medicinal plant industry were tackled in a concerted 
and coordinated fashion. 
 
1.3 Recent Developments in the Field of Traditional Medicine in Malaysia 
 
There has been a surge of public interest in traditional medicine in Malaysia. 
The National Committee on Medicinal Plants was set up in January 1995 as an 
Act of Parliament, following Cabinet approval. The Forest Research Institute 
Malaysia (FRIM) as the Secretariat of the Committee hosts the Traditional 
Medicine Section and has the task of charting out a strategic vision on the 
future of medicinal plants in the country in terms of the short, medium and long-
term approaches. 
 
The Minister of Health made a statement that the Medical Act will be amended 
to give traditional medicine a greater role in health care. Acknowledging that 
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plants hold the key to many remedies yet untapped, the Cabinet made a 
decision recently instructing the Institute of Medical Research (IMR) and Forest 
Research Institute Malaysia (FRIM) to study plants and document their curative 
properties (Anonymous, 1998). In recent years several seminars, conferences 
and forum have been organized which address specifically the topic of 
medicinal plants (Soepadmo et al., 1989; Khozirah et al., 1991; Chan et al., 
1993; MNPS, 1994 & FRIM, 1995). In addition, the Botany Departments of 
Universiti Malaya (UM), Universiti Kebangsaan Malaysia (UKM) and Universiti 
Putra Malaysia (UPM) have been actively involved in the botanical compilation 
of useful medicinal plants, whilst the ethnobotanical use of these species is of 
interest at FRIM, the Forestry Department and Institute of Medical Research 
(IMR). The School of Pharmacy Sciences, Universiti Sains Malaysia (USM), and 
the medical faculties of UKM and UM have made considerable progress on the 
pharmacological and phyotochemical aspects of specific medicinal plants 
(Kumari, 1996). 
 
This official endorsement of the Government comes as a culmination of years of 
effort by several individuals and agencies, including private practitioners, 
universities, FRIM and IMR. Ong (1997), stated that the Rimba Ilmu at Universiti 
Malaya (UM), with a collection of over 600 rare plant species represents one of 
the pioneering efforts towards in-situ conservation of medicinal plants in the 
country. Suhair (2003), has documented the medicinal properties of a hundred 
and sixteen species conserved in the herbal garden in Universiti Sains Malaysia 
(USM) and has been used as a reference for this study. 
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The recent developments in the medicinal plant field in Malaysia, taken isolated 
or collectively, suggest intuitively that the inherent economic value of medicinal 
plants must be quite significant. The current study, if carefully structured, could 
provide the necessary justification for the consolidation of the variety of 
activities currently underway in the medicinal plant programme in Malaysia. 
 
1.4 Objectives 
 
The objectives of the study were to: 
1. Identify and quantify traded medicinal plants resources available in the forest 
concession in order to document the biodiversity of the Lowland Inland 
Dipterocarp Forest in Pondok Tanjung Forest Reserve (PTFR), Larut 
Matang and Selama, Perak. 
2. Assessing the utilization of traded medicinal plants by interviewing the 
traditional medicinal practitioners (TMPs) as collectors and processors. 
3. Determine the estimated potential values of traded medicinal plants 
resources in the study sites.   
CHAPTER 2 
 
2.0 LITERATURE REVIEW 
 
2.1 Overview of the State of Medicinal Plants 
 
Medicinal plants constitute an important group among all of mankind's natural 
resources. Healing herbs have been traded and used since ancient times, but 
for all that they are neglected by mainstream development (Lambert et al., 
1996). It is estimated that about 250,000 plant species are found in the world, 
150,000 are distributed in the tropics, about 35,000 in Southeast Asia 
(Henderson, 1959) and not less than 6,000 species reported to have medicinal 
properties. Nonetheless, the conservation, cultivation, collecting and processing 
of medicinal plant raw materials constitutes a large formal market. Millions of 
people in developing countries use herbal medicines. In view of the growing 
momentum in traditional medicine worldwide, the current study is very timely. 
The international interest in medicinal plants is also reflected in the Malaysian 
scene where there has been a mushrooming activity of trade in medicinal plants 
(Kumari, 1996). 
 
The flora and fauna of tropical forests hold an astonishing cornucopia of 
medicines for traditional and industrial uses. Up to a quarter of the prescribed 
drugs used in the United States are derived from tropical rainforest plants. 
Nearly three-quarters of the 3,000 plants identified by the US National Cancer 
Institute as having anti-cancer properties comes from the rainforest. Quinine 
derived from the cinchona tree is used to treat malaria. Rainforest plants also 
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offer much promise of new treatments, particularly as cures for cancer and 
AIDS (Kumari, 1996). 
 
According to Li Chaojin (1987), traditional medicine is an integral part of the 
formal Health system and is utilized in about 40% of cases at the primary care 
level in China. Therefore, special encouragement has been given for the 
cultivation of medicinal plants since most of the crude drugs were formally 
collected in the wild and would be depleted if there were no measures taken. 
Agricultural departments in China at all levels take part in formulating policy and 
establishing plantations, which covered about 330,000 hectares in 1987. The 
escalating cost of sophisticated medical care and its dangers of over-medication 
of modern medicines also act as a factor why traditional medicines are known 
as the best alternative remedy to human being. 
 
Several African and Asian nations have just begun to encourage traditional 
medicine as an integral component of their public health care programs. The 
indigenous medicines are generally inexpensive, locally available and readily 
accepted by the local population (Prescott-Allen, 1982). India officially 
recognizes over 2500 plants as having medicinal value, and it is estimated that 
over 6000 plants are used in traditional, folk, and herbal medicine, representing 
about 75% of the medical needs of the Third World (Huxley, 1984). The focus 
on plants uses in traditional medicine by the World Health Organization (WHO) 
led to the initial identification of 20,000 species of which 200 have been 
selected for more detailed studies (Levingston & Zamora, 1983). 
 
 13
In United States of America where synthetics dominate the drug market scene, 
plant products still represent an important source of prescriptions dispensed 
from community pharmacies, and was valued at $US 8 billion in 1980 
(Farnsworth & Morris, 1976). In 1981, about 400 species of plants were 
reported in products marketed by the herbal industry in health-food stores 
throughout United States, and valued at $US 360 million (Wong & Taylor, 
1987). This number increased to $US 36 billion in 1994 (Hassler, 1995). In 
China and Japan, the market value was $US 2.5 billion and $US 5 billion 
(Kojima, 1995), respectively. The estimated global value of plant based drugs is 
$US 43 billion a year (FAO, 1997).  In Malaysia, the health food market is 
growing steadily at about 15 per cent per year. The market was valued at RM 
38 million in 1994 and is estimated to be RM 45 million by the end of 1995 
(Anonymous, 1994).  Recent  estimates  of the domestic market for 
pharmaceutical and herbal care products is RM 1 billion and RM 3 billion, 
respectively; and traditional medicine record annual sales of RM 2 billion 
(Anonymous, 1998) . 
 
2.2   Malaysian Forests as a Source of Medicinal Plants  
 
The Malaysian rain forests are endowed with high biological diversity. There are 
over 20,000 medicinal plant species (accounting for over 10% of the world’s 
total number of plant species) some of which are unique only to Malaysia 
(Soepadmo, 1992). Malaysia is rich in natural resources which are the basic 
requirement for traditional medicine. Traditional medicine is an integral part of 
Malaysian culture and has been practiced by various ethnic groups long before 
the introduction of the modern medicine system into the country. Much of the 
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knowledge is still dominant in the culture of the various ethnic groups in an 
unrecorded form. They are assumed to be passed from one generation to 
another in the traditional, oral manner. In Malaysia, the classical works of Burkill 
& Hanniff (1930); Gimlette & Burkill (1930) and Burkill (1935) represent the 
monuments of our knowledge on traditional medicine. 
 
According to Bidin & Latiff (1995), the flora of Malaysia is rich and a 
conservative estimate of the seed plants was about 12,500 species. Soepadmo 
et al., (2002) stated that about 1,200 species of higher plants in Peninsular 
Malaysia and 2,000 species in Sabah and Sarawak are reported to have 
medicinal values and have been used for generations in various traditional 
health care systems. These useful plants grow wild in the lowland and hill 
dipterocarp forest, which are under serious threat of being extinct. 
 
Of the more than 7,000 species of angiosperms and 600 species of ferns in 
Malaysia, about 1,082 species (about 15%) and 76 species (about 13%) 
respectively, are reported to have medicinal value were replaced by mono-
specific tree crops (rubber and oil palm), intensive logging to non–forestry land 
such as hydroelectric dams and rural settlements (Latiff et al., 1984). Various 
plant families such as those of the Euphorbiaceae, Leguminosae, Gramineae, 
Verbenaceae and others are commonly used to treat various ailments and 
diseases including diarrhea, skin problems and headache (Kumari, 1996). In 
Malaysia, the practice of traditional medicine is encouraged among various 
ethnic groups such as Malays, Chinese, Indian and aborigines where the 
knowledge has been passed down through generations. There are products 
derived from medicinal plants, which have economic value and have been 
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traded for years in Malaysia. These are Eurycoma longifolia, Areca catechu, 
Oldenlandia diffusa, Myristica fragrans, Piper nigrum and Melastoma 
decemfidum (Latiff, 1988).  Although it is known that the products are in 
favorable demand locally, information related to the price and availability of 
those plants is scarce. In Malaysia, the use of plant materials as traditional 
medicines either formally or informally is widespread among the local rural 
communities, especially the Malays, aborigines and others. Latiff (1988a) stated 
that there are four sources of Malaysian traditional medicine namely; Malay 
village medicine (including Orang Asli medicine), Chinese medicine (introduced 
from China), Indian medicine (introduced from India) and other traditional 
medicine (including those introduced by Javanese, Sumatrans, Arabs, Persians 
and Europeans).  
 
Burkill (1935) reported that more than 1300 plants have been used in traditional 
Malay medicine, although the system is not as well organized as the Indian and 
Chinese systems. The actual number of medicinal plants commonly used in the 
country was, however, indicated to be between 12 to 18 per cent of the claims 
(Sabariah, 1989), which approximates to 174 species. This figure is close to 
other estimates, which cited that the forests support more than 200 potentially 
important medicinal plants (Hurst, 1990). While some species are more popular 
than others, many form the minor ingredients of a decoction, or components of 
a wider curative concept. Given that thousands of plants in Malaysia have at 
one time or another been used for medicinal purposes, knowledge of such folk 
or ethnomedical uses could lead us to cut short the time required to discover 
modern therapeutic drugs from plants.  Every tribe and race has its own 
methods or ways of curing the affliction of diseases. It depends very much on 
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the practice, belief and knowledge each one possesses. Malaysia as a melting 
pot of the key ethnic cultures of Asia i.e. Malay, Chinese and Indian have a wide 
range of medicinal plant products available in the market. In addition, there are 
the medicinal plant products used by the indigenous tribes (Orang Asli) who live 
close to the forests or within them. The Orang Asli is renowned for their skills in 
combining herbal remedies from forest products. Their close relationship with 
the jungle is the basis for their survival despite the modern conveniences of 
Twentieth Century Malaysia. Those deep in the jungle still rely on traditional 
cures handed down through the generations. They use these plants in one form 
or another to cure or alleviate a variety of ills from bruises, bee or snake bites, 
tooth or stomach ache, rashes, kidney pains to healing hemorrhoids, tongue or 
mouth ulcers, bone fractures and malaria (Kumari, 1996). There are also 
preparations and infusions for diabetes, diarrhea, rheumatism, coughs, anemia 
and smallpox. Sometimes the same plants are used by the rural people for 
multi-purposes. For example, tubers of the black lily or ‘keladi murai’ (Tacca 
cristata) are used to treat rashes by Malay villagers, but the Orang Asli use the 
leaves as a hot poultice for rheumatism and aching limbs. Malays use the roots 
of Forrestia griffithi to treat fevers but the Orang Asli tribes use them for snake 
or centipede bites (Kress, 1995). 
 
For the Orang Asli, medicinal plants represented the only form of treatment 
available to them since modern medicine was not available. In the case of the 
Malays, there is often a preference for the traditional forms of medicine, 
especially in the very remote areas. Traditional herbal medicinal practices have 
persisted despite access to modern medicine. In many ways these are socially 
acceptable and have a wide cultural acceptance. The local Malay traditional 
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medicine is actually based on old Indonesian traditional medicine, which has 
been modified to suit the local and current needs (Muhamad & Mustafa, 1994).  
 
The increasing number of traditional medicine industries in Malaysia and the 
new approach of the production and marketing of the traditional medicine 
products also attracted people’s interest in using the products. With the modern 
approach (that is from the raw form which is now converted into capsule), the 
uses of the traditional medicine became more convenient and provided more 
confidence to users on the efficaciousness of the drugs. Furthermore, the 
medicinal plants product is believed to give no negative side effect to human 
body since there were no additional chemical drugs contents. The number of 
medicinal plant companies registered was increasing throughout the years and 
it is found that about 1,546 traditional medicine industries could be found in 
Peninsular Malaysia and Labuan since 1989 (Mohd. Azmi & Ahmad Fauzi, 
1998) 
 
In Malaysia, the proper statistics on the production of NTFPs are still lacking 
and difficult, as it was not properly formulated at the initial project. The same 
situation also occurs in the development of NTFPs resources. Most of the 
information with regard to the development of NTFPs only confined to rattan 
and bamboo. Rattan and bamboo were two of the main NTFPs that have been 
given attention due to their economic potential. This reflected that the economic 
contribution of NTFPs based on the market values is still lower than timber. 
Statistic on the export of medicinal plants in Malaysia was estimated at about 
RM 55 million (Ng and Mohd Azmi, 1997) and RM 43 million (Anonymous, 
1998) in 1996 and 1997, respectively. Studied by Mohd Azmi & Ahmad Fauzi 
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(1998) showed that the supply of Eurycoma longifolia (Tongkat Ali), one of the 
most famous medicinal plants in Malaysia, found that the average collection of 
E. longifolia roots and stems per trip in Kedah (based on ten respondents) was 
10.7 kg or 154.1 kg per month. Therefore, the total collection of E. longifolia per 
year was 26,568 kg (by estimating that each respondent had an average of two 
trips of harvesting per month). By taking an average price of E. longifolia is at 
RM 13.50 per stem, the market value of resources was estimated about 
RM358, 670 per year or RM29, 890 per month. 
 
There were no accurate data or information could quantify the use of raw 
materials from the wild by traditional medicinal industries. Therefore, it is difficult 
to recognize and estimate how much raw materials of medicinal plants had 
been collected and utilized and which plants is mostly needed by industries. 
However, study by Ng and Mohd Azmi (1997) showed that the trade of 
medicinal plants (raw materials and plant products) for ten years period in 
Malaysia was quite significant. It showed that our imports are always exceeding 
our exports since 1986 (Table 2.1). This shows that most of the raw materials 
used in the industries came from outside sources such as China, India and 
Indonesia which is mostly imported by Chinese and Indian traditional medicine 
industries.  
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 Table 2.1: Trade of Medicinal Plants in Malaysia (1986-1998) 
Year Imports (RM) Exports (RM) 
1986 95,267,763 4,171,067 
1987 87,654,774 5,227,073 
1988 153,086,351 8,192,234 
1989 168,694,676 12,263,211 
1990 166,850,230 16,777,638 
1991 187,156,231 18,725,948 
1992 206,482,164 10,053,811 
1993 223,901,918 21,925,302 
1994 234,722,844 34,951,451 
1995 271,325,265 41,241,046 
1996 276,729,402 55,871,852 
1997* 209,995,087 42,839,514 
1998* 187,450,382 34,312,514 
 
Source: Department of Statistics Malaysia, (1999). 
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Figure 2.1: Trade of Medicinal Plants in Malaysia (1986-1998) 
 
As shown in Table 2.1 and Figure 2.1, the imports of medicinal plants increased 
about 2.0% to 82.5% from 1987 to 1996 although there was a slight decrease in 
1990 (1.1%). This shows that during the ten years period the traditional 
medicine industries have a tremendous utilization of imported raw materials and 
plant products for their production. By looking at the export pattern of medicinal 
plants, the scenario is basically the same as imports through the years. There 
was an increase in the exports of medicinal plants from 1986 to 1996 (as was 
the imports) about 11.6% to 118.1% and a slight decrease during 1992 (46.3%). 
This shows that beside imports, raw materials of traditional medicine and plant 
products in Malaysia had a great demand in Denmark and Asian countries such 
as Singapore, Thailand and Brunei. 
 
The import of medicinal plants started to decline in 1997 (about 24.1%) due to 
the economic downturn in Malaysia. The same situation is recorded in 1998, 
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where about 10.7% of the imports were in declined. It is assumed that during 
1997 and 1998, the industries are using alternative raw materials that could be 
found internally as a substitute to the imported raw materials previously or they 
tried to minimize cost by decreasing their production. The same situation was 
also shown in the export trend of medicinal plant during those years. The 
exports of the medicinal plants declined about 23.3% and 19.9% in 1997 and 
1998 respectively. The economic downturn that affected Malaysian currency 
could have contributed to the problems. 
 
2.3 Valuation Methods of NTFPs Resources 
 
Economists generally depend on market prices to indicate the value of NTFPs.  
For particular NTFPs, which are traded in the market, information on the prices, 
quantities, cost of harvesting and other parameters can be obtained through 
market survey. However, not all NTFPs have market prices and their values 
would have to be estimated through other methods such as substitute good 
approach. There are many classifications of values and benefits found in the 
literature (Barbier, 1992; Munasinghe, 1993 & Pearce, 1993) as shown in Table 
2.2  
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Table 2.2:  Valuation of NTFPs to Determine Economic Value                     
NTFPs Type of  
Use 
Traded  /  
Non - Traded 
Valuation Technique 
Rattan Direct Traded (International) Market-based technique 
Bamboo Direct Traded (local) Market-based technique 
Medicinal  
Plants 
Direct Traded 
(local/International) 
Market-based technique, 
Substitute good approach, 
Contingent valuation method 
Fruit trees Direct Some are traded local Market-based technique  
Substitute good approach, 
Contingent valuation method 
Recreation Direct Non-traded Travel cost method, 
Contingent valuation method 
Water or 
hydrological 
values 
Direct Traded and own 
consumption 
Market-based technique, 
Contingent valuation method 
Wildlife Direct Traded 
(International/local) & 
non-traded     
Market-based technique 
 Substitute good approach, 
Contingent valuation method    
Palms    
 
 
Direct Some are locally traded Market-based technique, 
Substitute good approach, 
Contingent, valuation method  
Essential oils 
(Keruing oils) 
Direct Traded (International) Market-based technique, 
Foods Direct Some are traded locally Market-based technique, 
Contingent valuation method, 
Substitute good approach 
Carbon Indirect Traded (International) 
(carbon-offset) 
Market-based technique 
Resin Direct Traded Market-based technique 
Latex Direct Traded Market-based technique 
Honey               Direct Traded                 Market-based technique           
Climbers     
 
            
Direct Some are traded Market-based technique, 
Contingent valuation method, 
Substitute good approach       
Gaharu  
(Karas)   
Direct      Traded (International) Market-based technique       
 
Protected 
areas 
(national 
park) 
Direct, 
Indirect 
Not traded Contingent valuation method, 
Choice modeling 
Research Direct Not traded Replacement Cost 
Education Direct Not traded Replacement Cost 
Soil 
protection 
Indirect Not traded Damage cost avoided 
Genetic 
resources 
Direct Some are traded Hedonic pricing, market price 
Aesthetic 
value 
Indirect Not traded Hedonic pricing 
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Direct use values refer to the productive or consumptive values of ecosystem 
components or functions. Direct uses may be marketed or non-marketed, with 
some of the activities often being important for the subsistence needs of local 
communities. An example of a marketed direct use is timber resource, which 
can be harvested and sold to consumers. The use of medicinal herbs collected 
from the forest resources by local communities is an example of non-marketed 
direct use. Marketed uses may be important for both domestic and international 
markets. In general, the value of marketed goods and services is easier to 
measure than the value of non-marketed and subsistence direct uses.  
 
Indirect use values refer to the value of environmental functions that support or 
protect an economic activity. For instance, a tropical forest protects watersheds 
and store carbon dioxide. Tropical forests also include many plant species, 
which in turn may have established ecological functions. The values of 
environmental functions can be derived from the supporting or protecting 
economic activities that have directly measurable values (IIED, 1994). 
 
The methods used to determine each value mentioned above depends on the 
nature of forest goods and services in question. For the direct use value, the 
methods available include market-based technique, changes in productivity 
approach, relocation cost, and damage cost avoided. The indirect use value, 
the contingent valuation approach can be used to value option and existence 
values. This method requires good understanding of forest goods and services 
production system. A good literature on the methods used can be found in 
Hanley & Spash  (1993); IIED (1994). 
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